A comprehensive genomic analysis of the Plasmodium falciparum, the most lethal malaria parasite, has identified potential new targets for the development of more effective drug therapies.
This new antibiotic may finally put a stop to some of the world's most drug-resistant pathogens
Zosurabalpin, a new antibiotic in development by Roche, shows promise in combating multi-drug resistant Gram-negative bacteria, potentially transforming treatment approaches.
This new antibiotic may finally put a stop to some of the world's most drug-resistant pathogens
Zosurabalpin, a new antibiotic in development by Roche, shows promise in combating multi-drug resistant Gram-negative bacteria, potentially transforming treatment approaches.
New gonorrhoea treatment hailed as breakthrough in fight against drug resistance
The discovery of gepotidacin offers a vital new treatment option for gonorrhoea, potentially reducing the impact of drug-resistant strains and enhancing patient experience.